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Background: A tandem technique of hard equipment is often used for the chemical analysis of a single cell to first
isolate and then detect the wanted identities. The first part is the separation of wanted chemicals from the bulk of
a cell; the second part is the actual detection of the important identities. To identify the key structural modifications
around ligand binding, the present study aims to develop a counterpart of tandem technique for cheminformatics.
A statistical regression and its outliers act as a computational technique for separation.
Results: A PPARγ (peroxisome proliferator-activated receptor gamma) agonist cellular system was subjected to such
an investigation. Results show that this tandem regression-outlier analysis, or the prioritization of the context
equations tagged with features of the outliers, is an effective regression technique of cheminformatics to detect key
structural modifications, as well as their tendency of impact to ligand binding.
Conclusions: The key structural modifications around ligand binding are effectively extracted or characterized out
of cellular reactions. This is because molecular binding is the paramount factor in such ligand cellular system and
key structural modifications around ligand binding are expected to create outliers. Therefore, such outliers can be
captured by this tandem regression-outlier analysis.Background
In any chemical analysis of a single cell, the first step is
the separation of wanted chemicals from the bulk of a
cell. This is due to the fact that a cellular system has a
complex, heterogeneous composition. Various methods
[1] using hard equipment have been developed for such
uses. After a single cell is separated from the other cells,
the wanted component can be further isolated and then
detected through what is called a tandem technique [1].
The first part of a tandem technique, as mentioned above,
is the separation of wanted chemicals from the bulk of a
cell; the second part is the detection of the components.
By mimicking such a tandem technique, a computational
counterpart was developed herein; a statistical regression
and its outliers (influential observations [2]) act as a com-
putational technique for separation, which can cause the
important identities (i.e. the factors causing outliers) to beCorrespondence: ytlin@kmu.edu.tw
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reproduction in any medium, provided the orisolated from the bulk of a cellular system. As a pioneer
investigation, one molecular descriptor and one class of
descriptors will be prepared: the descriptor resembles
the filter in the tandem equipment; the class resembles
the detector.
In a ligand-dependent receptor-mediated cellular system
(or ligand cellular system), key structural modifications
surrounding ligand binding are expected to cause outliers.
For example, hydrogen bond formation, or deformation,
can cause drastic alterations in cellular reaction. These
singular situations are, at times, the reasons for statistical
breakdown points in many analyses that are otherwise
correct (i.e. resulting in the outliers of a statistical regres-
sion [3,4]). At the same time, such outliers can have the
most prominent and often most informative features of
the target-specific activity landscapes [5]. Therefore, the
concept that after this tandem regression-outlier analysis,
the features of these resulting outliers can correspond to
important structural modifications around molecular
binding in such a ligand cellular system, if correct, would
be very useful.is is an Open Access article distributed under the terms of the Creative
commons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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tative descriptor for the bulk system of a cell. We found
Jurs_RNCG [6], after observing more than 521×17 data
sets of PPARγ (peroxisome proliferator-activated receptor
gamma) agonists [7-21]. The methods and results are
depicted in the first body of materials, methods, and
results. To connect this to the second tandem part, the
descriptor that is sought in the first part has functionality,
which yields outlier residues for the second part.
Acting as an assay for detection in the second tandem
part, for which the electrotopological state (ES) class of
descriptors [22-26] is used. All possible structural modi-
fications in a given collected analog set are pre-assigned
by ES descriptors. The ES descriptors involve atom types
in various electro-topological states. For example, in ES
terminology, an ES_Count_ssO of a molecular structure is
the count of “ssO” linkages, and here the “ssO” represents
a bonding oxygen atom (O) linked via two single bonds
(ss). A structural modification is considered a fundamental
element (an action) for the reaction of such a ligand
cellular system. In actuality, any structural modification of
such an analog set can be expressed by the change of an
associated ES descriptor. The details and results of the
second part are also depicted in the second body of
materials, methods and results.
This tandem regression-outlier technique is, therefore,
in mathematical terms, carried out so as to prioritize the
context equations tagged with features of these outliers.
We want to know if the top-ranked structural modifications
correspond to the key interactions around molecular
binding as we expected them to. This expectation was
based on the fact that: I: this singular situation causes
outliers in a regression. II: molecular binding is the
paramount factor in such a ligand cellular system, and
III, key structural modifications around ligand binding
are expected to create singular situations, i.e. cause
outliers in a statistical regression.
In the end, after this tandem regression-outlier analysis
for the PPARγ agonist cellular system, a top ranked ES
symbol can faithfully correspond to key interactions around
molecular binding with the correct order of potency. The
outcome of such an analysis confirmed the two main
underlying and mutually-dependent speculations; one being
that, in the second tandem part, the top ranked ES symbols
reflect the key interactions around ligand binding, and the
other that, in the first tandem part, the designation of
Jurs_RNCG (relative negative charge) can effectively
remove the general effects of such a ligand cellular system.
Methods
The first tandem filter: in order to seek the most
representative descriptor for a ligand cellular system
In mathematics, the dependent variable Y is the ligand-
dependent receptor-mediated cellular reaction. Thecontext equation of the descriptor selection is given
as follows:
Y ¼ β0 þ βchXch ð1Þ
where Y is the dependent variable that stands for the
ligand-dependent receptor-mediated cellular reaction,
Xch is the descriptor to be chosen, and β0 and βch are
the regression coefficients after the least squares fit.
Once the ligand-dependent receptor-mediated cellular
data of a given set of analogs are available, the r2 correlation
fit can be obtained for each descriptor. Here, 521 descrip-
tors of eminent classes are used. All descriptors in the
working equation with correlation fits are prioritized by
correlation coefficient. All calculations of descriptors
were performed using the Discovery Studio 2.1 QSAR
module [27]. The regression fits were conducted for
each descriptor in the context equation and Pearson’s
coefficients were performed using R 2.11.0 [28].
The second tandem detector: to prioritize the context
equations tagged with all possible features of the outliers
Following the designation of the Jurs_RNCG descriptor, a
three-variable equation is used for the prioritization of all
the ES descriptors. The context equation using Jurs_RNCG,
tagged with all possible features of the outliers, is given
as follows:
Y ¼ β0 þ βJurs RNCGJurs RNCGþ βESES ð2Þ
where Y is the dependent variable standing for the
ligand-dependent receptor-mediated cellular reaction,
Jurs_RNCG is the calculated Jurs descriptor, ES are all
the possible ES descriptors; and all βs are the estimated
regression coefficients after the least squares fit. The
context equations tagged with all possible ES descriptors
are prioritized by correlation coefficient. 12 top-ranked ES
descriptors monitored in the table indicate 12 important
structural modifications in a given analog set.
Materials
Three data sets of analogs with two cores
To demonstrate the ability of this tandem regression-
outlier analysis to remove all interference from any
general effects in a ligand cellular system, three data sets
of the ligand-dependent receptor-mediated data are used
here. The first data set is a collection of 46 PPARγ agonists
with the thiazolidinedione (TZD) core. The second data set
is composed of 178 PPARγ agonists with a carboxylic acid
core. The third data set is a merger of the first and second
data set (i.e., 224 PPARγ agonists mixed with both TZD
and carboxylic acid cores). The two main cores of PPARγ
agonists and their merger are adopted, so as to observe the
variations of top-ranked structural modifications. All EC50
(50% efficacy concentration) data were extracted from the
Table 1 Dominant descriptors for each data size and the
frequency of Jurs_RNCG (Jurs type descriptors)

















100 ICa (Jurs_RNCG) 19/31/521
110 Jurs_RNCG 16/21/521
120 Num_AtomClasses (Jurs_RNCG) 21/23/521
130 ICa (Jurs_RNCG) 28/29/521
140 ICa (Jurs_RNCG) 39/306/521
150 Jurs_RNCG 39/39/521
160 ICa (Jurs_RNCG) 53/53/521
170 Jurs_RNCG 369/369/521
a The descriptors SC_3_P and IC are calculated based on graph theory.
b The descriptor ES_Count_dO is a fractional descriptor (The definition of a
fractional descriptor is in the discussion section).
Agonists of each data set are selected out of the 178 carboxylic acid PPARγ
agonists. The top-ranked descriptor of each set was selected from 521
descriptors of eminent classes.
Table 2 The top-ranked ES descriptors of 46 TZD PPARγ
agonists
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http://www.jcheminf.com/content/5/1/21literature [7-21]. The cellular reaction is the measurement
of the activation of PPARγ within the construct of the
cellular transactivation assays. Indeterminate and uncertain
EC50 values were excluded. A negative logarithm of the
EC50 values of PPARγ agonists was then taken. The
original publication of all agonists and the activity
quantities are listed in Additional file 1: Tables S1 and S2.
All images of molecular structures were created by using
Pybel [29,30]. All molecular structures were energetically
geometry-optimized using molecular mechanics and
MMF97 calculations, which were implemented using the
ChemBio3D software of the ChemBioOffice package [31].
Results
Jurs_RNCG as most representative descriptor
In the mathematical formulation in the first tandem
filter, we used a large number data set, or 178 collected
carboxylic acid PPARγ agonists, as a base to seek the
most representative descriptor. More details about PPARγ
agonists are available in Material Section. To check the size
dependency, for each data size from 10 to 170, a total of
521 × 17 data sets were taken for the selection of the
descriptor just for the enough randomness. Sample agonists
of each size were picked out by prioritizing 521 molecular
properties. The dominant descriptor and the frequency of
the Jurs type descriptor for each size, including Jurs_RNCG
[6], is listed in Table 1. For example, in the data size of 170
agonists, the dominant descriptors of 369 data sets among
a total of 521 sets are all Jurs_RNCG. We can clearly see
that when the data size increases, the Jurs_RNCG is more
frequently dominant or near dominant (rank > 4). In Jurs
terminology, RNCG means a relative negative charge [6].
In a realistic physical-chemical representation, one would
prefer the Jurs_RNCG to the IC (Information Content) [32]
as the most representative descriptor for all general effects.
This is because Jurs_RNCG was originally designed based
on the charge-related nature. The descriptor IC, as an index
of graph theory, deals with the topological aspect in nature.
Therefore, the Jurs_RNCG descriptor here is thought to be
the most representative single descriptor for all general ef-
fects in the PPARγ agonist cellular system. After this desig-
nation, to our surprise, the Jurs_RNCG is further shown to
be a linear combination of three important descriptors:
LogD (partition coefficient), PSA (polar surface area), and
shape-like descriptors in a subsequent work [33]. These
three descriptors happen to be the three most important
factors of investigation in medicinal chemistry over the past
50 years [34].
Top-ranked ES descriptors as important structural
modifications around ligand binding
Table 2 lists the 12 top-ranked ES descriptors for the 46
TZD PPARγ agonists after the conduct of prioritization in
the second tandem detector. Table 3 lists the 12 top-rankedES descriptors for the 178 carboxylic acid PPARγ agonists.
Table 4, which is the merger of the two former sets, lists
the 12 top-ranked ES descriptors for the 224 PPARγ
agonists. The striking feature in all three tables is that
the ES symbol, ssO, ranks in the first position. ‘s’ indicates a
Table 3 The top-ranked ES descriptors of 178 carboxylic
acid PPARγ agonists













Lin Journal of Cheminformatics 2013, 5:21 Page 4 of 9
http://www.jcheminf.com/content/5/1/21single bond. ‘ss’ indicates two single bonds linked in struc-
ture. This feature reflects a key interaction between potent
agonist and PPARγ receptors, which shows concurrence
with the inference of the X-ray crystallography depicted in
the next section.
To begin with, in Table 2, the ES_Count_ssO and
ES_Sum_ssO rank in most top positions with a negative
regression coefficient. Basically, this is a negative struc-
tural modification with respect to cellular reaction. But
care should be taken here: this does not mean that the
existence of ssO moiety in the structure is bad. On the
contrary, the existence of single ssO moiety is extremely
good. (We can read this from the most potent leads
which all have tyrosine moiety.) When examining the
original data, each collected TZD PPARγ agonist has at
least one ssO moiety in the structure, here known as an
oxygen atom in tyrosine moiety. The correct interpretation
for the sign of such a symbol here therefore is that theTable 4 The top-ranked ES descriptors of 224 PPARγ
agonists with both TZD and carboxylic acid cores












Count_aaN 12 +introduction of more than one ssO moiety importantly
decreases cellular reaction. Rosiglitazone, an established
drug that is one of the collected TZD agonists, shows
this corresponding feature with the ES symbol, ssO in
Figure 1(a).
Next, the ES symbol sssN, indicates the introduction
of a tertiary amine (sssN) moiety, which is a positive
structural modification. ‘sss’ indicates three single bonds
linked in structure. Nine agonists have 1 sssN moiety of
the 46 collected agonists. The corresponding feature of
the ES symbol, sssN, in the tertiary amine (sssN) moiety,
is shown in Figure 1(b).
The next ES symbol in Table 2 is ssCH2. The positive
regression coefficient indicates that the elongation of a
ligand structure through the addition of carbon moiety
(ssCH2) is a positive structural modification. This
topological elongation of the agonist makes a large impact
to the molecular binding. However, we notice that the
ssCH2 symbol is negative in Table 3. And, when combining
two data sets in Table 4, the topological structural
modification ssCH2 falls out of the monitor table.
Apparently, the suitable length of the TZD agonist is
optimal for cellular binding.
The ES symbol following this in Table 2 is aaO. ‘aa’
indicates oxygen atom in an aromatic ring. Throughout
the whole 46 TZD agonists there are only two agonists:
AD-7075 and BRL48482, in Figure 1(c), that have the
oxazole moiety. We notice that these two agonists serve
as very good examples of “analog outliers”, which bear
specific feature of outliers The other ES symbols, aaO,
aaN and aaCH, also indicate this oxazole moiety. The
5-methyl-oxazole of AD-7075 has the additional symbols
aasC and sCH3 whereas the benzo-oxazole of BRL48482
has the additional symbol aaaC. Taken together, the
significance of oxazole moieties are faithfully pointed
out by these symbols. The other monitored symbols,
sCH3 and dsCH, indicate other, less important, structural
modifications.
Lastly, in Table 3 and Table 4, we find a similar picture
regarding the potency order of structural modifications.
The top ES symbol, ssO, represents the most important
structural modification, tyrosine moiety, performed on the
middle part of PPARγ agonist. The rest of the top-ranked
ES symbols represent important structural modifications
done to the tail part. For example, a fmoc-like moiety
(fluorenylmethyloxycarbonyl-like), other than oxazole
moiety and tertiary amine, is another case which has
an ES symbol of significance: aaaC. Again, serving as
analog outliers, these two potent agonists [18] are
shown in Figure 1(d).
There is one more observation: we can clearly see that
no ES symbol regarding TZD moieties, dssC, dO, sssCH,
ssNH, or ssS, appears in Table 2; and we can also see




















Figure 1 Molecular structures of: (a) Rosiglitzaone with tyrosine moiety (ssO), (b) Rosiglitzaone with tertiary alkylamine moiety (sssN),
(c) AD-7075 and BRL48482 with oxazole moiety (aaO), and (d) Two carboxylic acid agonists with Fmoc-like moiety (aaaC). All moiety
structures are colored in blue and the atom of the ES symbol is colored in red.
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http://www.jcheminf.com/content/5/1/21sOH, appear in Table 3. ‘d’ indicates double bond. When
combining the two data sets, no ES symbols regarding
TZD or carboxylic acid appear in Table 4. There are two
simple interpretations of this: 1, the lack of modification
of the core part of analogs in a given set will naturally
lead to no ES symbols monitored in the table, and 2, a
core shift in the combined set without causing a large
difference of reaction will not produce related ES
symbols of significance. Thus, in conclusion, the TZD
and carboxylic acid are known as the necessary parts
of full PPARγ agonists without synthetic modifications.
The necessity of two essential cores for full cellular activity
can be immediately inferred when comparing the inactive
compounds at initial synthesis.
The top-ranked ES symbols point out key ligand binding
interactions
As mentioned in the introduction, we would like to see
if the top-ranked ES descriptor finds its corresponding
key interactions for molecular binding. In this section
we examine real physical pictures. First, in Table 2, the
top-ranked ES symbols are ssO and sssN. We can go to
the crystallographic image of the rosiglitazone-PPARγ
complex (PDB code: 2PRG) [35]. Figure 2 shows, around
the bound structure of rosiglitazone, that the ES symbol
ssO can detect the key interaction between rosiglitazone









Figure 2 Illustration of the top-ranked ES symbols, ssO and sssN. Arou
ssO can detect the key interaction between rosiglitazone ether oxygen and
important ES symbol, sssN, detects the key interaction between rosiglitazon
Leu340 backbone oxygen (4.46 Å). Notice that all the measured distances a
the X-ray crystallography.Met364 (4.70 Å). Another important ES symbol, sssN,
detects the key interaction between rosiglitazone tertiary
amine nitrogen and Cys285 side-chain sulfur (4.44 Å), or
Leu340 backbone oxygen (4.46 Å). We noticed that all the
measured distances are between relevant heavy atoms
because hydrogen is transparent in X-ray crystallography.
Second, in Table 3, the top-ranked ES symbols are ssO
and aaO. We then look at the crystallographic image of
the 1K74 ligand-PPARγ complex (PDB code: 1K47) [36].
Figure 3 shows that, around the bound structure of the
1K47 ligand, a important ES symbol, ssO, can detect the
key interaction between 1K74 ligand ether oxygen and
Cys285 side-chain sulfur (3.63 Å) or Met364 sulfur
(4.87 Å). Another important ES symbol, aaO, detects
the key interactions between 1K74 ligand oxazole oxygen
and Cys285 side-chain sulfur (3.61 Å). Here we also
measured the distance (4.95 Å) between oxazole nitro-
gen (aaN) and Leu340 backbone oxygen. The symbol,
aaN, as a important structural modification of the tail
part, is indicated in Tables 2 and 4. More ES symbols
regarding the tail part modifications of PPARγ agonists, as
mentioned above, can also detect their corresponding key
interactions in other crystallographic images of potent
PPARγ agonists.
Taken together, these correspondences clearly point
out that the top-ranked ES symbols are the key structural




nd the bound structure of rosiglitazone (PDB: 2PRG), the ES symbol
the two sulfurs of Cys285 (3.79 Å) and Met364 (4.70 Å). Another
e trialkylamine nitrogen and Cys285 side-chain sulfur (4.44 Å), or














Figure 3 Illustration of the top-ranked ES symbols ssO, aaO, and aaN. Around a bound structure of 1K47 ligand (PDB: 1k47), the important
ES symbol ssO can detect the key interaction between 1K74 ligand ether oxygen and Cys285 side-chain sulfur (3.63 Å) or Met364 sulfur (4.87 Å).
Another key ES symbol, aaO, detects the key interactions between 1K74 ligand oxazole oxygen and Cys285 side-chain sulfur (3.61 Å). Here we
also measured the distance (4.95 Å) between oxazole nitrogen (aaN) and Leu340 backbone oxygen.
Table 5 The ES symbols monitored in the Table 2 are
intentionally combined in a single fitting equation
# Equation
1 Y = 4.97 − 20.8Jurs _ RNCG − 2.81 Count _ ssO + 0.38 Sum _ ssO *
2 Y = 3.41 − 4.50 Jurs_RNCG − 3.09 Count_ssO
+ 0.47 Sum_ssO * + 0.95 Sum_sssN − 0.86 Count_ssN *
3 Y = 3.34 − 11.1 Jurs_RNCG − 0.33 Count_ssO + 0.31 Count_sssN
+ 0.47 Count_aaO − 0.33 Count_sCH3 − 0.079 Count_aaN *
*The coefficient signs of these ES symbols labeled with star signs (*) contradict
the ones presented in Table 2.
Three fitting equations with signs of regression coefficients are presented.
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Jurs_RNCG as a filter
The descriptor Jurs_RNCG acts as a filter. One might
expect to see some outcomes if the single Jurs_RNCG
descriptor is not included, i.e. there is no first filter of
this tandem technique. Apparently, all general effects will
contribute to the top-ranked ES descriptor. In Additional
file 1: Table S3, for example, the top-ranked ES symbol,
ssO, tyrosine moiety, of PPARγ agonists, falls outside the
monitor table. In other words, we need a descriptor in
the first regression that can effectively remove the general
effect of a ligand cellular system. As mentioned above, one
purpose for using Jurs_RNCG is to leave outliers for the
second part.
Moreover, the potency orders and tendencies (signs of
regression coefficients) of structural modifications coincide
with our knowledge about the structural modifications of
PPARγ agonists. So the top-ranked structural modifications
can detect their corresponding key interactions surround-
ing molecular binding, as shown in the X-ray image of a
potent agonist-PPARγ complex. The outcomes of such a
regression-outlier analysis also tell us that the Jurs_RNCG
is truly an adequate filter.
In addition, and exceeding our expectations, the
Jurs_RNCG can be expressed in a linear combination of
partition coefficients, polar surface area, and shape-like
descriptors [33], which further reveals three essential
factors for drug-cell interfaces in such a ligand cellular
system [34].Three types of dependency in the top-ranked ES descriptors
For a closer inspection of the top-ranked ES descriptors,
the ES symbols from Table 2 were intentionally combined
in a single fitting equation. Three fitting equations are
listed in Table 5. First, in Equation 1 of Table 5, the ES
symbol Sum_ssO, has a positive regression coefficient op-
posite to the sign presented in Table 2. In Equation 2, the
symbol Count_sssN, has a negative regression coefficient
opposite to the sign provided in Table 2. At the same time,
we noticed that the correlation (r) between Count_ssO and
Sum_ssO in this 46 TZD data set is +0.98 and the correl-
ation (r) between Count_sssN and Sum_sssN is +0.99; i.e.,
they have extremely significant positive correlations. In
the interest of realistic representation, it is impossible
that an identical important structural modification be
represented by two highly positive-correlated descrip-
tors indicating different tendencies. However, the fitting
regression coefficient resulting in the different signs in
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and Sum_ssO (or, the Count_sssN and Sum_sssN) have a
dependency of description on identical structural
modification.
Second, by removing the modification description
dependency, the Count and Sum values of the same ES
symbol are not in the same equation. In Equation 3 of
Table 5, the symbol Count_aaN has a negative regression
coefficient compared to the sign listed in Table 2. It
therefore contradicts the observation that the captured
symbols, aaO, aaaC, sssN, aaNH, and aaN, represent
positive structural modifications to the tail part of
PPARγ agonists. Obviously, in this equation form 3,
the symbols aaO and sssN represent the identical key
interaction in the tail part of PPARγ agonists, and the
simultaneous appearance of them for the same moiety
turned the regression coefficient of the additional aaN
into the opposite sign. Thus, one can say here that the
ES symbols aaN, aaO and sssN have dependency of
description on the identical moiety.
Third, throughout all of the 46 TZD PPARγ agonists,
when examining the values of the symbol aaO and
related structural moieties, we found that no structural
moiety contains this aaO feature aside for oxazole. The
moiety oxazole exists only in the two potent agonists
AD-7057 and BRL48482 [10]. The value of ES_Count_aaO
is 1 for these 2 agonists whereas the value is 0 for the
rest of collected PPARγ agonists. The ES symbols of
oxazole have aaO, aaN, and aaCH. Four agonists have
the aaN structural moiety of these 46 collected agonists
and, among those four, two compounds are AD-7057
and BRL48482. Moreover, all agonists have the aaCH
structural moiety, but the symbol aaCH does not
appear in Table 2. Clearly, the symbols aaO, aaN and
aaCH have unequal dependencies of description in
these data samples.
Especially, these dependencies of descriptor will actually
cause serious consequence to all QSARs of four categories
(classical, 3-dimensional, decisional and orthogonal)
[37-39], their existence would make a model lose its
interpretability. Put together, the three types of de-
pendencies in the top-ranked ES symbols actually play
a major role in the design of the context equation.
That is, two ES symbols don’t appear simultaneously
in a context equation. Obviously, if one forces two
dependent ES descriptors to be combined in a single
equation, the signs in the regression coefficients of key
structural modifications may change, and thus fail to
point out the real tendency of impact to ligand binding
in an analog set. If one mixes two ES descriptors in a
single equation acting as a detector, the one in this
regression-outlier analysis will lose its ability to correctly
detect the real tendencies of key structural modifications
in the given analog sets.Conclusions
The innovative point of the present study is the fact that
we used a statistical regression and its outlier as a
computational technique for separation. This technique
was used specifically in the ligand cellular system. As a
counterpart to the hard equipment in the tandem tech-
nique, the prior molecular descriptor resembles a filter
that removes the influence from the bulk of a cell and
the latter class of descriptors is an array of detectors
that can identify any important identities. In the case of
the PPARγ agonist cellular system, the key structural
modifications surrounding ligand binding were successfully
detected and the tendencies of impact were examined.
In the end, after the tandem regression-outlier analysis
of this ligand cellular system, the results show that this
prioritization of the context equations (filter) tagged with
features of outliers (detector) is an effective computational
tool for cheminformatics to detect possible features of
outliers (key structural modifications), as well as their
impact tendencies to ligand binding.
Additional file
Additional file 1: Table S1. Lists the structures of the TZD PPARγ
agonists with their activities. All images of molecular structures were
created by using Pybel [29,30]. Table S2 lists the structures of the
Carboxylic (COOH) PPARγ agonists with their activities. All images of
molecular structures were created by using Pybel [29,30]. Table S3 lists
the top-ranked ES descriptors of 178 carboxylic acid PPARγ agonists
against cellular reactions, without the inclusion of Jurs_RNCG.
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